Precision radiotherapy with MRI-guided technology
Part of Cancer, Injuries & trauma clinical trials.
This trial tests a new type of radiotherapy that uses MRI scans to guide the radiation beam more precisely. It aims to treat tumors while reducing damage to healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have had an MRI scan or treatment with the MR-linac machine
- Your overall health status allows daily activities (ECOG 0-2) and you are expected to live more than 6 months
- You do not have any metal implants or devices that are not safe for MRI
- You are not pregnant, nursing, or planning to get pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows what happens when radiation treatment is guided using an MR-Linac (a special machine that combines MRI imaging with radiation). It may help improve how radiation therapy is planned and assessed, especially for people who can safely have MRI scans.
This study checks whether a new MRI-guided radiation machine (MR-Linac) can be used safely and properly for people receiving radiation therapy. You might help the team confirm it works in real-world patients by being treated with this MR-Linac setup.
This trial checks whether it’s practical and safe to deliver radiation treatment using real-time MRI guidance, with the process supported online. It may help patients whose doctors recommend radiation by testing a modern way to plan and deliver treatment more precisely.
This trial studies a way of planning and delivering radiation using MRI pictures to help target tumors more accurately. It may benefit people by improving how radiation is aligned, and it’s being tested for safety and effectiveness compared with the usual CT-based planning.
This trial tests a precise type of radiation (stereotactic body radiotherapy) using a special MRI-guided machine for lung tumors that are very close to the main airways. It might help patients who cannot have surgery and whose tumor is in a hard-to-treat spot.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
Hear when a new Overall Response Rate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.